The positive regulation of p53 by the tumor suppressor VHL

被引:46
作者
Roe, Jae-Seok [1 ]
Youn, Hong-Duk [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Canc Res Inst,Interdisciplinary Program Genet Eng, Seoul 110799, South Korea
关键词
von Hippel-Lindau; p53; tumor suppressor; ATM; histone acetyltransferase; transactivation;
D O I
10.4161/cc.5.18.3247
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ubiquitin-mediated degradation of hypoxia-inducible factor-alpha (HIF-alpha) by a von Hippel-Lindau tumor suppressor protein (pVHL) is mechanistically responsible for controlling gene expression due to oxygen availability. Germline mutations in the VHL gene cause dysregulation of HIF and induce an autosomal dominant cancer syndrome referred to as VHL disease. However, it is unclear whether HIF accumulation caused by VHL mutations is sufficient for tumorigenesis. Recently, we found that pVHL directly associates and positively regulates the tumor suppressor p53 by inhibiting Mdm2-mediated ubiquitination, and by subsequently recruiting p53-modifying enzymes. Moreover, VHL-deleted RCC cells showed attenuated apoptosis or abnormal cell-cycle arrest upon DNA damage, but became normal when pVHL was restored. Thus, pVHL appears to play a pivotal role in tumor suppression by participating actively as a component of p53 transactivation complex during DNA damage response.
引用
收藏
页码:2054 / 2056
页数:3
相关论文
共 32 条
[1]   Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1α expression [J].
Bárdos, JI ;
Chau, NM ;
Ashcroft, M .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2905-2914
[2]   The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis [J].
Barry, RE ;
Krek, W .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (09) :466-472
[3]  
Bento JC, 2005, HAEMATOLOGICA, V90, P128
[4]   Role of exon 2-encoded β-domain of the von Hippel-Lindau tumor suppressor protein [J].
Bonicalzi, ME ;
Groulx, I ;
de Paulsen, N ;
Lee, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1407-1416
[5]   Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation [J].
Brooks, CL ;
Gu, W .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :164-171
[6]   Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 [J].
Canman, CE ;
Lim, DS ;
Cimprich, KA ;
Taya, Y ;
Tamai, K ;
Sakaguchi, K ;
Appella, E ;
Kastan, MB ;
Siliciano, JD .
SCIENCE, 1998, 281 (5383) :1677-1679
[7]   HIF-1α and p53:: the ODD couple? [J].
Fels, DR ;
Koumenis, C .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (08) :426-429
[8]   Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain [J].
Gu, W ;
Roeder, RG .
CELL, 1997, 90 (04) :595-606
[9]   p53 pathway in renal cell carcinoma is repressed by a dominant mechanism [J].
Gurova, KV ;
Hill, JE ;
Razorenova, OV ;
Chumakov, PM ;
Gudkov, AV .
CANCER RESEARCH, 2004, 64 (06) :1951-1958
[10]   HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing [J].
Ivan, M ;
Kondo, K ;
Yang, HF ;
Kim, W ;
Valiando, J ;
Ohh, M ;
Salic, A ;
Asara, JM ;
Lane, WS ;
Kaelin, WG .
SCIENCE, 2001, 292 (5516) :464-468